CN Patent

CN120081840A — 一种非奈利酮-马来酸共晶及其制备方法

Assigned to Shandong Chengchuang Blue Sea Pharmaceutical Technology Co ltd · Expires 2025-06-03 · 1y expired

What this patent protects

本申请属于医药领域，具体涉及了一种非奈利酮与马来酸的药物共晶及其制备方法。本申请制备的非奈利酮与马来酸的药物共晶，具有纯度高、溶解度适宜、稳定性良好等适合新药开发和工业化生产。本申请提供的非奈利酮与马来酸的药物共晶的制备方法，工艺路线简单、成本低廉，适宜工业化生产。

USPTO Abstract

本申请属于医药领域，具体涉及了一种非奈利酮与马来酸的药物共晶及其制备方法。本申请制备的非奈利酮与马来酸的药物共晶，具有纯度高、溶解度适宜、稳定性良好等适合新药开发和工业化生产。本申请提供的非奈利酮与马来酸的药物共晶的制备方法，工艺路线简单、成本低廉，适宜工业化生产。

Drugs covered by this patent

Patent Metadata

Patent number
CN120081840A
Jurisdiction
CN
Classification
—
Expires
2025-06-03
Drug substance claim
No
Drug product claim
No
Assignee
Shandong Chengchuang Blue Sea Pharmaceutical Technology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.